Ellerson Group’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.85M | Sell |
5,431
-2,711
| -33% | -$1.42M | 2.01% | 22 |
|
|
2025
Q1 | $5.16M | Buy |
8,142
+1,222
| +18% | +$775K | 4.11% | 4 |
|
|
2024
Q4 | $4.93M | Buy |
6,920
+59
| +0.9% | +$42K | 3.6% | 7 |
|
|
2024
Q3 | $7.21M | Sell |
6,861
-127
| -2% | -$134K | 5.66% | 3 |
|
|
2024
Q2 | $7.34M | Sell |
6,988
-84
| -1% | -$88.3K | 5.59% | 4 |
|
|
2024
Q1 | $6.81M | Sell |
7,072
-23
| -0.3% | -$22.1K | 5.2% | 4 |
|
|
2023
Q4 | $6.23M | Hold |
7,095
| – | – | 5.41% | 4 |
|
|
2023
Q3 | $5.84M | Sell |
7,095
-134
| -2% | -$110K | 5.44% | 4 |
|
|
2023
Q2 | $5.19M | Buy |
7,229
+170
| +2% | +$122K | 4.95% | 4 |
|
|
2023
Q1 | $5.8M | Sell |
7,059
-4
| -0.1% | -$3.29K | 6.29% | 4 |
|
|
2022
Q4 | $5.1M | Buy |
+7,063
| New | +$5.1M | 5.4% | 3 |
|